Routes of
administration Injection Bioavailability <3% (oral) CAS Number 183747-35-5 Molar mass 965.016 g/mol | ATC code None Biological half-life 44 minutes (IV) PubChem CID 3086682 | |
 | ||
How to pronounce nepadutant
Nepadutant (INN) (code name MEN-11420) is a glycosylated bicyclic cyclohexapeptide drug which acts as a highly selective NK2 receptor antagonist. It was developed by the Menarini Group and investigated for the treatment of functional gastrointestinal disorders and asthma but was never marketed.
References
Nepadutant Wikipedia(Text) CC BY-SA